Your browser is no longer supported. Please, upgrade your browser.
Settings
ATNM Actinium Pharmaceuticals, Inc. daily Stock Chart
ATNM [NYSE]
Actinium Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.55 Insider Own0.10% Shs Outstand58.43M Perf Week-2.86%
Market Cap59.60M Forward P/E- EPS next Y-0.58 Insider Trans- Shs Float54.10M Perf Month-15.70%
Income-28.00M PEG- EPS next Q-0.14 Inst Own6.40% Short Float3.15% Perf Quarter-34.19%
Sales- P/S- EPS this Y8.90% Inst Trans0.05% Short Ratio4.31 Perf Half Y3.17%
Book/sh0.23 P/B4.43 EPS next Y-3.60% ROA-140.60% Target Price6.63 Perf Year-40.00%
Cash/sh0.29 P/C3.49 EPS next 5Y- ROE-174.30% 52W Range0.86 - 2.15 Perf YTD16.57%
Dividend- P/FCF- EPS past 5Y34.90% ROI- 52W High-52.56% Beta1.72
Dividend %- Quick Ratio3.40 Sales past 5Y- Gross Margin- 52W Low18.60% ATR0.07
Employees23 Current Ratio3.40 Sales Q/Q- Oper. Margin- RSI (14)34.89 Volatility3.25% 5.89%
OptionableYes Debt/Eq0.00 EPS Q/Q-45.00% Profit Margin- Rel Volume0.33 Prev Close1.02
ShortableYes LT Debt/Eq0.00 EarningsAug 14 AMC Payout- Avg Volume395.15K Price1.02
Recom1.70 SMA20-8.36% SMA50-19.24% SMA200-16.84% Volume129,337 Change0.00%
Aug-25-16Initiated ROTH Capital Buy $5
Feb-29-16Initiated H.C. Wainwright Buy $8
Oct-15-15Initiated FBR Capital Outperform $12
Oct-01-14Initiated MLV & Co Buy $16
Jul-22-14Initiated Canaccord Genuity Buy $16
Jul-18-17 03:24PM  Trump cant let Obamacare fail but he can help destroy it Yahoo Finance
Jul-13-17 07:00AM  Actinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ET GlobeNewswire
Jul-06-17 07:30AM  Actinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ET GlobeNewswire
Jun-15-17 08:30AM  Actinium Pharmaceuticals Issues Mid-Year Letter to Shareholders Highlighting Accomplishments and Significant Value Enumerating Catalysts Over the Coming Quarters GlobeNewswire +6.48%
07:00AM  Actinium Pharmaceuticals Announces Appointment of Nitya Ray, Ph.D. as Executive Vice-President, Head of Product Development, Manufacturing and Supply Chain and Other Key Hires in its Product Development and Manufacturing Teams GlobeNewswire
Jun-12-17 07:00AM  Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B GlobeNewswire -6.85%
Jun-09-17 07:30AM  Actinium Pharmaceuticals Announces Appointment of Sandesh Seth as Chief Executive Officer GlobeNewswire
Jun-08-17 07:30AM  Actinium Pharmaceuticals Highlights Presence at Upcoming Society of Nuclear Medicine and Molecular Imaging Annual Meeting GlobeNewswire
07:00AM  UPDATE Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B GlobeNewswire
May-31-17 07:30AM  Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B GlobeNewswire
May-24-17 09:23AM  Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A GlobeNewswire
May-23-17 07:30AM  Actinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha Therapy GlobeNewswire +5.26%
May-17-17 07:00AM  Actinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory Board GlobeNewswire -5.07%
May-12-17 02:03PM  Anthem Denies Cigna Breakup Fee as Merger Bid Crumbles TheStreet.com
May-10-17 07:00AM  Actinium Pharmaceuticals Receives Clearance from Health Canada to Initiate Pivotal Phase 3 SIERRA Trial of Iomab-B GlobeNewswire +5.97%
Apr-18-17 07:00AM  Actinium Pharmaceuticals Announces Sponsorship of the Acute Leukemia Forum 2017 GlobeNewswire
Mar-28-17 04:35PM  ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial +5.33%
07:00AM  Actinium Pharmaceuticals Appoints Pharmaceutical Industry Executive Ajit S. Shetty, Ph.D., to the Companys Board of Directors GlobeNewswire
Mar-22-17 01:13PM  Moleculin Leukemia Drug Gets Orphan Drug Status Investopedia
01:04PM  ACTINIUM PHARMACEUTICALS, INC. Financials
Mar-21-17 01:46PM  Actinium Gets Positive CHMP Opinion for AML Drug Investopedia
01:46PM  Actinium Gets Positive CHMP Opinion for AML Drug at Investopedia
12:55PM  Actinium Pharmaceuticals (ATNM) Receives New Patents, Boosts its Portfolio Accesswire
12:29PM  Actinium Pharmaceuticals (ATNM) Receives New Patents, Boosts Its Portfolio
07:00AM  Actinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-B GlobeNewswire
Mar-16-17 05:30PM  Actinium Pharmaceuticals to Sponsor 4th Annual Summit on Hematologic Malignancies GlobeNewswire
04:32PM  ACTINIUM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Mar-07-17 07:00AM  Actinium Pharmaceuticals to Present at 29th Annual ROTH Conference GlobeNewswire
Feb-28-17 07:00AM  Actinium Announces Expansion of Intellectual Property Portfolio with Notice of Allowance for U.S. Patent Related to Actimab-A, Actimab-M and the Companys Technology Platform GlobeNewswire
Feb-23-17 07:00AM  Actinium Pharmaceuticals Announces Active Presence at the BMT Tandem Meetings GlobeNewswire -7.79%
Feb-21-17 07:00AM  Actinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice President, Clinical and Commercial Strategy GlobeNewswire
Feb-14-17 07:00AM  Actinium Pharmaceuticals to Attend the BMT Tandem Meetings, the Combined Annual Meetings of Two Leading Transplant Organizations GlobeNewswire
Feb-13-17 04:15PM  Actinium Pharmaceuticals to Present at Source Capital Groups 2017 Disruptive Growth & Healthcare Conference GlobeNewswire
07:00AM  Actinium Pharmaceuticals Company Presentation at BIO CEO & Investor Conference to Provide Highlights of Recently Announced Actimab-M Trial in Multiple Myeloma GlobeNewswire
Feb-10-17 01:16PM  Actinium Pharmaceuticals (ATNM) has Considerable Potential in 2017 Accesswire
11:09AM  Actinium Pharmaceuticals (ATNM) has Considerable Potential in 2017
Feb-09-17 07:00AM  Actinium Pharmaceuticals to Present at BIO CEO & Investor Conference GlobeNewswire +20.16%
Feb-07-17 04:45PM  Actinium Pharmaceuticals Is Better Than Celator
08:00AM  Actinium Pharmaceuticals Announces Pipeline Expansion with Initiation of Clinical Trial of Actimab-M in Multiple Myeloma GlobeNewswire
Feb-06-17 09:30AM  Key Catalyst That Could Send Biotechs Soaring in 2017: Today's Reports on MYOS RENS Technology and Actinium Pharmaceuticals Accesswire
Jan-24-17 07:00AM  Actiniums Chief Medical Officer, Dr. Mark Berger, to Present Talk Titled, Iomab-B: Radiolabeled CD45 at the 3rd Annual Expert Forum on Acute Leukemias and Myeloproliferative Neoplasms GlobeNewswire
Jan-20-17 07:00AM  Actinium Announces Participation in Three Upcoming Hematology Events GlobeNewswire
Jan-18-17 08:00AM  Actinium Strengthens Executive Team and Enhances Clinical Development Capabilities with the Appointment of Dr. Mark Berger as Chief Medical Officer GlobeNewswire
Jan-10-17 07:00AM  Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase 2017 Conference GlobeNewswire
Jan-04-17 09:00AM  The Life Sciences Report Announces 19 Companies Selected for the 2017 Small-Cap Biotech Watchlist Marketwired
07:00AM  Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase 2017 Conference GlobeNewswire
Dec-22-16 08:05AM  ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Dec-19-16 07:00AM  Actinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of Analytical Development to Support BLA and IND Enabling Analytical Studies for Current and Future Clinical Programs GlobeNewswire
Dec-14-16 05:14PM  ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a
Dec-13-16 07:00AM  Actinium Pharmaceuticals Announces Submission of EU Orphan Designation Application for Actimab-A GlobeNewswire
Dec-12-16 07:00AM  Actinium to Sponsor Upcoming Blood & Marrow Transplant Information Network Webinar Focused on Stem Cell Transplants for Patients with AML GlobeNewswire
Dec-06-16 10:10AM  Actinium Pharmaceuticals, Inc. :ATNM-US: Earnings Analysis: Q3, 2016 By the Numbers : December 6, 2016
Dec-05-16 09:00PM  Actinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual Meeting GlobeNewswire
Nov-29-16 07:00AM  Actinium Further Strengthens Clinical Development Team with Senior Hire to Support Later-Stage Clinical Trials GlobeNewswire
Nov-22-16 07:00AM  Actinium Issues Letter to Shareholders Highlighting 2016 Accomplishments and Anticipated Milestones for 2017 GlobeNewswire
Nov-21-16 07:00AM  Actinium Pharmaceuticals to Present at LD Micro Main Event Investor Conference GlobeNewswire
Nov-14-16 07:00AM  Actinium Announces Notice of Allowance for U.S. Patent Related to Actimab-A GlobeNewswire
Oct-31-16 07:00AM  Actinium Pharmaceuticals Announces Key Hire in Clinical Supply Chain Organization as Company Expands To Accommodate Continued Growth GlobeNewswire -6.86%
Oct-28-16 05:04PM  ACTINIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Oct-26-16 07:00AM  Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth GlobeNewswire +6.80%
Oct-25-16 07:00AM  Actinium Pharmaceuticals Initiates Pursuit of Scientific Advice for Iomab-B from the European Medicines Agency GlobeNewswire
Oct-21-16 06:45PM  [$$] Clinical Development News, Oct. 17-21 at The Wall Street Journal
Oct-19-16 07:00AM  Actinium Announces Acceptance of Actimab-A Data for Poster Presentation at American Society of Hematology Annual Meeting GlobeNewswire
Oct-18-16 07:00AM  Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Iomab-B GlobeNewswire
Oct-04-16 04:15PM  Actinium Announces Closing of Public Offering of Common Stock GlobeNewswire
Sep-29-16 11:34AM  Why PepsiCo, Philip Morris, Fitbit, and Two Other Stocks Are Making Headlines Today at Insider Monkey -21.76%
08:46AM  ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosu
08:16AM  Actinium Announces Pricing of Public Offering of Common Stock GlobeNewswire
Sep-28-16 04:10PM  Actinium Announces Proposed Public Offering of Common Stock GlobeNewswire
Sep-27-16 07:00AM  Actinium Announces Initiation of Phase 2 Clinical Trial of Actimab-A in Patients Newly Diagnosed with Acute Myeloid Leukemia Over Age 60 GlobeNewswire -15.00%
Sep-26-16 07:00AM  Actinium Pharmaceuticals to Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant GlobeNewswire +11.73%
Sep-21-16 08:00AM  Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial GlobeNewswire +6.71%
Sep-20-16 12:19PM  Actinium Pharmaceuticals, Inc. :ATNM-US: Earnings Analysis: Q2, 2016 By the Numbers : September 20, 2016
07:00AM  Actinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial GlobeNewswire
Sep-19-16 07:00AM  Actinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference GlobeNewswire
Sep-13-16 07:00AM  Actinium Pharmaceuticals Presenting at Rodman & Renshaw 18th Annual Global Investment Conference GlobeNewswire
Sep-09-16 07:00AM  Actinium Pharmaceuticals Presenting at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference GlobeNewswire
Sep-07-16 07:00AM  Actinium Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams GlobeNewswire
Aug-30-16 07:00AM  Actinium to Present at Rodman & Renshaw 18th Annual Global Investment Conference Marketwired +6.46%
Aug-26-16 12:00PM  These 5 Stocks Are Breaking Out
Aug-25-16 08:20AM  Coverage initiated on Actinum Pharma by ROTH Capital
Aug-23-16 07:00AM  Actinium Pharmaceuticals to Present at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference Marketwired
Aug-18-16 09:00AM  The Life Sciences Report Examines Actinium's Radioimmunotherapies Marketwired
Aug-09-16 07:00AM  Actinium Pharmaceuticals Granted SME Status by the European Medicines Agency; Reiterates Focus on EU Market Marketwired
Aug-04-16 08:01AM  ACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:00AM  Actinium Pharmaceuticals Issues Mid-Year Letter to Shareholders Providing Update on Company Progress and Anticipated Milestones Marketwired
Jul-29-16 04:48PM  ACTINIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Jul-27-16 12:11PM  Actinium: Another Promising Name in the AML Space Accesswire
11:49AM  Actinium Pharmaceuticals: Another Promising Name In The AML Space
Jul-20-16 07:00AM  Actinium Pharmaceuticals Highlights Successful Investigator Meeting for Pivotal Phase 3 Iomab-B SIERRA Trial Marketwired
Jul-12-16 07:00AM  Actinium Receives Assignment of Intellectual Property From Memorial Sloan Kettering Cancer Center Specific to Actinium's APIT Platform and the Use of Actinium-225 Marketwired
Jul-06-16 07:00AM  Actinium Pharmaceuticals to Sponsor Investigator Meeting for Pivotal Phase 3 SIERRA Trial for Iomab-B Marketwired
Jun-29-16 07:00AM  Actinium Pharmaceuticals Initiates Pivotal Phase 3 SIERRA Trial Marketwired
Jun-28-16 07:00AM  Actinium Sponsored Acute Myeloid Leukemia (AML) Awareness Month to Feature Webinar Focused on Transplantation as a Treatment Option for Blood Cancers Marketwired
Jun-15-16 07:00AM  Actinium Sponsored Acute Myeloid Leukemia (AML) Awareness Month Continues With Medical Update Webinar Marketwired
Jun-09-16 07:00AM  Actinium Announces Strong Presence at Society of Nuclear Medicine and Molecular Imaging Annual Meeting Marketwired
Jun-08-16 06:08PM  Actinium Pharmaceuticals, Inc. :ATNM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016
07:00AM  Actinium to Present at BIO International Convention to Provide Updates on Actimab-A and Iomab-B Programs Marketwired
Jun-02-16 07:00AM  Actinium Pharmaceuticals Applauds CancerCare(R) for Launching the First Ever Acute Myeloid Leukemia Awareness Month Marketwired -5.47%
Jun-01-16 03:10PM  Why Galena Biopharma, Whole Foods, Ocean Power Tech, Actinium Pharma & Shopify Spiked Today at Insider Monkey
Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted payload immunotherapeutics for the treatment of advanced cancers. The company's proprietary platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its lead product candidate is Iomab-B that is in Phase III clinical studies in refractory or relapsed acute myeloid leukemia (AML) patients over the age of 55 for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. The company is also developing Actimab-A, which is in Phase II clinical trials for the treatment of patients newly diagnosed with AML over the age of 60; and Actimab-M that is in Phase I clinical trials for patients with relapsed or refractory multiple myeloma. In addition, it utilizes its alpha-particle immunotherapy technology platform to generate new drug candidates based on antibodies linked to the element Actinium-225 that are directed at various cancers that are blood-borne or form solid tumors. Actinium Pharmaceutical, Inc. was founded in 2000 and is based in New York, New York.